235 related articles for article (PubMed ID: 11818297)
1. Prevalence of medication treatment for attention deficit-hyperactivity disorder among elementary school children in Johnston County, North Carolina.
Rowland AS; Umbach DM; Stallone L; Naftel AJ; Bohlig EM; Sandler DP
Am J Public Health; 2002 Feb; 92(2):231-4. PubMed ID: 11818297
[TBL] [Abstract][Full Text] [Related]
2. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
3. Attention-Deficit/Hyperactivity Disorder (ADHD): Interaction between socioeconomic status and parental history of ADHD determines prevalence.
Rowland AS; Skipper BJ; Rabiner DL; Qeadan F; Campbell RA; Naftel AJ; Umbach DM
J Child Psychol Psychiatry; 2018 Mar; 59(3):213-222. PubMed ID: 28801917
[TBL] [Abstract][Full Text] [Related]
4. Studying the epidemiology of attention-deficit hyperactivity disorder: screening method and pilot results.
Rowland AS; Umbach DM; Catoe KE; Stallone L; Long S; Rabiner D; Naftel AJ; Panke D; Faulk R; Sandler DP
Can J Psychiatry; 2001 Dec; 46(10):931-40. PubMed ID: 11816314
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of prescribed attention-deficit hyperactivity disorder medications and diagnosis among Canadian preschoolers and school-age children: 1994-2007.
Brault MC; Lacourse É
Can J Psychiatry; 2012 Feb; 57(2):93-101. PubMed ID: 22340149
[TBL] [Abstract][Full Text] [Related]
6. Stimulant treatment in Maryland public schools.
Safer DJ; Malever M
Pediatrics; 2000 Sep; 106(3):533-9. PubMed ID: 10969099
[TBL] [Abstract][Full Text] [Related]
7. Are there placebo effects in the medication treatment of children with attention-deficit hyperactivity disorder?
Waschbusch DA; Pelham WE; Waxmonsky J; Johnston C
J Dev Behav Pediatr; 2009 Apr; 30(2):158-68. PubMed ID: 19363369
[TBL] [Abstract][Full Text] [Related]
8. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
Visser SN; Lesesne CA; Perou R
Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
[TBL] [Abstract][Full Text] [Related]
9. [Children's relative age in class and medication for attention-deficit/hyperactivity disorder. A population-based study in a health department in Spain].
Librero J; Izquierdo-María R; García-Gil M; Peiró S
Med Clin (Barc); 2015 Dec; 145(11):471-6. PubMed ID: 25913908
[TBL] [Abstract][Full Text] [Related]
10. Student-Perceived School Climate Is Associated With ADHD Medication Treatment Among Adolescents in Medicaid.
Visser SN; Kramer D; Snyder AB; Sebian J; McGiboney G; Handler A
J Atten Disord; 2019 Feb; 23(3):234-245. PubMed ID: 25710947
[TBL] [Abstract][Full Text] [Related]
11. Examination of DSM-IV criteria for attention deficit/hyperactivity disorder in a county-wide sample.
Wolraich ML; Hannah JN; Baumgaertel A; Feurer ID
J Dev Behav Pediatr; 1998 Jun; 19(3):162-8. PubMed ID: 9648041
[TBL] [Abstract][Full Text] [Related]
12. Physician Office Visits for Attention-deficit/Hyperactivity Disorder in Children and Adolescents Aged 4-17 Years: United States, 2012-2013.
Albert M; Rui P; Ashman JJ
NCHS Data Brief; 2017 Jan; (269):1-8. PubMed ID: 28135186
[TBL] [Abstract][Full Text] [Related]
13. A survey of medication treatment for hyperactive/inattentive students.
Safer DJ; Krager JM
JAMA; 1988 Oct; 260(15):2256-8. PubMed ID: 2902237
[TBL] [Abstract][Full Text] [Related]
14. [Relationship Between Age of School Entry and Behaviour Problems].
Schmiedeler S; Segerer R; Schneider W
Prax Kinderpsychol Kinderpsychiatr; 2015; 64(2):104-16. PubMed ID: 25716621
[TBL] [Abstract][Full Text] [Related]
15. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
Winterstein AG; Gerhard T; Shuster J; Zito J; Johnson M; Liu H; Saidi A
Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics.
Bussing R; Narwaney KJ; Winterstein AG; Newton DA; DeBar L; Boscarino JA; Toh S; Pawloski P; Nordin JD; Herrinton LJ; Mason D; Daley MF
Curr Med Res Opin; 2014 Aug; 30(8):1687-99. PubMed ID: 24635013
[TBL] [Abstract][Full Text] [Related]
17. Attention-deficit hyperactivity disorder in Manitoba children: medical diagnosis and psychostimulant treatment rates.
Brownell MD; Yogendran MS
Can J Psychiatry; 2001 Apr; 46(3):264-72. PubMed ID: 11320681
[TBL] [Abstract][Full Text] [Related]
18. Attention deficit/hyperactivity disorder in primary school children of Tabriz, North-West Iran.
Amiri S; Fakhari A; Maheri M; Mohammadpoor Asl A
Paediatr Perinat Epidemiol; 2010 Nov; 24(6):597-601. PubMed ID: 20955237
[TBL] [Abstract][Full Text] [Related]
19. Common Danish standards in prescribing medication for children and adolescents with ADHD.
Dalsgaard S; Humlum MK; Nielsen HS; Simonsen M
Eur Child Adolesc Psychiatry; 2014 Sep; 23(9):841-4. PubMed ID: 24374648
[TBL] [Abstract][Full Text] [Related]
20. A National Profile of Attention-Deficit Hyperactivity Disorder Diagnosis and Treatment Among US Children Aged 2 to 5 Years.
Danielson ML; Visser SN; Gleason MM; Peacock G; Claussen AH; Blumberg SJ
J Dev Behav Pediatr; 2017 Sep; 38(7):455-464. PubMed ID: 28723824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
